… of the PhACs was affected by the salinity build-up in the bioreactor, with reduction in
biodegradation after 32 d. However, salinity increment had little or no effect on biosorption …

… membrane bioreactor coupled with a membrane distillation system (AnOMBR-MD) for removing
… Reduction in salinity in the bioreactor could result in better biodegradation of recalcitrant …

… , the microbial removal of six pharmaceuticals was investigated in a membrane bioreactor at
… In order to get more insights about the (in)complete degradation of some pharmaceuticals in …

… of these pharmaceuticals by microorganisms. The study demonstrated that the … removal
mechanism of pharmaceuticals in SMBR at optimized treatment conditions was biodegradation …

… that pharmaceutical and personal care product (PPCP) removal … , while low degradation for
diltiazem and no degradation but only … Table 2 depicts the removal of selected ECs via MBRs …

… including pharmaceuticals, endocrine disrupting compounds, and personal … ’ removal,
and to determine whether it is possible to establish biomasses able to degrade compounds that …

… However, they observed that only around 26% was a result of biodegradation, while the
biodegradation observed in this research was around 69.20 ± 1.54% (Fig. 2). Therefore, it was …

… to those of conventional biological treatment processes. In this study, the removal of
pharmaceutical compounds by membrane bioreactors under different solid retention times (SRTs) …

… Membrane bioreactors combined with biodegradation and … over the other treatment techniques
in the removal of … evacuation of pharmaceutical compounds in membrane bioreactor that …

… , removal of nitrogen species and eliminating the need for tertiary treatments have been
implicated in membrane bioreactors (… These pharmaceuticals were completely degraded and/or …